James E. Froeschle

944 total citations
26 papers, 672 citations indexed

About

James E. Froeschle is a scholar working on Epidemiology, Microbiology and Infectious Diseases. According to data from OpenAlex, James E. Froeschle has authored 26 papers receiving a total of 672 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 12 papers in Microbiology and 8 papers in Infectious Diseases. Recurrent topics in James E. Froeschle's work include Bacterial Infections and Vaccines (11 papers), Pneumonia and Respiratory Infections (6 papers) and Peripheral Neuropathies and Disorders (4 papers). James E. Froeschle is often cited by papers focused on Bacterial Infections and Vaccines (11 papers), Pneumonia and Respiratory Infections (6 papers) and Peripheral Neuropathies and Disorders (4 papers). James E. Froeschle collaborates with scholars based in United States, France and Finland. James E. Froeschle's co-authors include Robert Ryall, James C. King, Margaret B. Rennels, Thomas Papa, Heidi Åhman, Helena Käyhty, Odile Leroy, Juhani Eskola, Lisa A. Jackson and Barbara Carste and has published in prestigious journals such as JAMA, PEDIATRICS and Clinical Infectious Diseases.

In The Last Decade

James E. Froeschle

25 papers receiving 618 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
James E. Froeschle United States	16	455	384	153	63	59	26	672
M Schlumberger France	12	338 0.7×	257 0.7×	149 1.0×	56 0.9×	19 0.3×	30	539
Jerry Labadie Netherlands	13	324 0.7×	220 0.6×	127 0.8×	19 0.3×	32 0.5×	22	561
Olivier Van Der Meeren Belgium	15	550 1.2×	328 0.9×	217 1.4×	52 0.8×	21 0.4×	40	709
Linda Diggle United Kingdom	14	839 1.8×	521 1.4×	134 0.9×	18 0.3×	53 0.9×	24	1.1k
H.L. Bock Germany	18	728 1.6×	345 0.9×	399 2.6×	125 2.0×	54 0.9×	46	1.2k
Heinz J. Schmitt Germany	9	417 0.9×	189 0.5×	107 0.7×	20 0.3×	17 0.3×	9	508
Emmanuel Vidor France	15	348 0.8×	224 0.6×	212 1.4×	135 2.1×	12 0.2×	29	563
Roland Sänger Germany	19	697 1.5×	274 0.7×	184 1.2×	29 0.5×	10 0.2×	24	881
H. Bogaerts Germany	18	689 1.5×	597 1.6×	262 1.7×	101 1.6×	11 0.2×	32	897
Inger Lise Haugen Norway	14	302 0.7×	228 0.6×	75 0.5×	11 0.2×	20 0.3×	16	498

Countries citing papers authored by James E. Froeschle

Since Specialization

Citations

This map shows the geographic impact of James E. Froeschle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James E. Froeschle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James E. Froeschle more than expected).

Fields of papers citing papers by James E. Froeschle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James E. Froeschle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James E. Froeschle. The network helps show where James E. Froeschle may publish in the future.

Co-authorship network of co-authors of James E. Froeschle

This figure shows the co-authorship network connecting the top 25 collaborators of James E. Froeschle. A scholar is included among the top collaborators of James E. Froeschle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James E. Froeschle. James E. Froeschle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Froeschle, James E. & Michael D. Decker. (2009). Duration of Vi antibodies in participants vaccinated with Typhim Vi (Typhoid Vi polysaccharide vaccine) in an area not endemic for typhoid fever. Vaccine. 28(6). 1451–1453. 15 indexed citations

Jackson, Lisa A., Maya Dunstan, Onchee Yu, et al.. (2008). Prospective Assessment of the Effect of Needle Length and Injection Site on the Risk of Local Reactions to the Fifth Diphtheria-Tetanus-Acellular Pertussis Vaccination. PEDIATRICS. 121(3). e646–e652. 24 indexed citations

Marcus, Leonard C., James E. Froeschle, David R. Hill, et al.. (2007). Safety of Typhim Vi Vaccine in a Postmarketing Observational Study. Journal of Travel Medicine. 14(6). 386–391. 12 indexed citations

Froeschle, James E., et al.. (2006). Safety and Immunogenicity of a New Chromatographically Purified Rabies. Journal of Travel Medicine. 11(4). 195–200. 11 indexed citations

Rennels, Margaret B., James C. King, Robert Ryall, Thomas Papa, & James E. Froeschle. (2004). Dosage Escalation, Safety and Immunogenicity Study of Four Dosages of a Tetravalent Meninogococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine in Infants. The Pediatric Infectious Disease Journal. 23(5). 429–435. 80 indexed citations

Rennels, Margaret B., James C. King, Robert Ryall, et al.. (2002). Dose escalation, safety and immunogenicity study of a tetravalent meninogococcal polysaccharide diphtheria conjugate vaccine in toddlers. The Pediatric Infectious Disease Journal. 21(10). 978–979. 37 indexed citations

Froeschle, James E., et al.. (2002). Immediate Hypersensitivity Reactions after Use of Tuberculin Skin Testing. Clinical Infectious Diseases. 34(1). e12–e13. 17 indexed citations

Jackson, Lisa A., et al.. (2002). Retrospective population-based assessment of medically attended injection site reactions, seizures, allergic responses and febrile episodes after acellular pertussis vaccine combined with diphtheria and tetanus toxoids. The Pediatric Infectious Disease Journal. 21(8). 781–786. 44 indexed citations

Liese, Johannes G., et al.. (2001). Safety and immunogenicity of Biken acellular pertussis vaccine in combination with diphtheria and tetanus toxoid as a fifth dose at four to six years of age. The Pediatric Infectious Disease Journal. 20(10). 981–988. 26 indexed citations

10.

Jackson, Lisa A., et al.. (2001). Diphtheria Antitoxin Levels among Children Primed with a Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Lot with a Subpotent Diphtheria Toxoid Component. The Journal of Infectious Diseases. 183(11). 1698–1700. 4 indexed citations

11.

Ruben, Frederick L., James E. Froeschle, Carlton Meschievitz, et al.. (2001). Choosing a Route of Administration for Quadrivalent Meningococcal Polysaccharide Vaccine: Intramuscular versus Subcutaneous. Clinical Infectious Diseases. 32(1). 170–172. 15 indexed citations

12.

Jones, Robert L., James E. Froeschle, Robert L. Atmar, et al.. (2001). Immunogenicity, safety and lot consistency in adults of a chromatographically purified Vero-cell rabies vaccine: a randomized, double-blind trial with human diploid cell rabies vaccine. Vaccine. 19(32). 4635–4643. 31 indexed citations

13.

Froeschle, James E.. (1999). Meningococcal Disease in College Students. Clinical Infectious Diseases. 29(1). 215–216. 35 indexed citations

14.

Åhman, Heidi, et al.. (1998). Streptococcus pneumoniae capsular polysaccharide-diphtheria toxoid conjugate vaccine is immunogenic in early infancy and able to induce immunologic memory. The Pediatric Infectious Disease Journal. 17(3). 211–216. 108 indexed citations

15.

Vadheim, Constance M., David P. Greenberg, S. Michael Marcy, James E. Froeschle, & Joel I. Ward. (1990). Safety evaluation of PRP-D Haemophilus influenzae type b conjugate vaccine in children immunized at 18 months of age and older. The Pediatric Infectious Disease Journal. 9(8). 555–561. 10 indexed citations

16.

Marchant, Colin D., et al.. (1989). Depression of anticapsular antibody after immunization with Haemophilus influenzae type b polysaccharide-diphtheria conjugate vaccine. The Pediatric Infectious Disease Journal. 8(8). 508–510. 17 indexed citations

17.

Froeschle, James E., et al.. (1967). PARALYTIC POLIOMYELITIS IN LARGE LABORATORY PRIMATES1. American Journal of Epidemiology. 85(2). 229–239. 12 indexed citations

18.

Froeschle, James E.. (1967). Hand, Foot, and Mouth Disease (Coxsackievirus A16) in Atlanta. Archives of Pediatrics and Adolescent Medicine. 114(3). 278–278. 25 indexed citations

19.

Froeschle, James E. & Helen Casey. (1965). Simultaneous administration of oral polio vaccine and globulin-modified attenuated measles-virus vaccine. The Journal of Pediatrics. 66(6). 1031–1034. 5 indexed citations

20.

Froeschle, James E. & William C. Reeves. (1965). SEROLOGIC EPIDEMIOLOGY OF WESTERN EQUINE AND ST. LOUIS ENCEPHALITIS VIRUS INFECTION IN CALIFORNIA. American Journal of Epidemiology. 81(1). 44–51. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact